You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

60 Results
Regimen
Cancer Type:
Gynecologic, 
Uterine Sarcoma, 
Sarcoma, 
Uterine
Intent: Palliative
Feb 2018
Regimen
Cancer Type:
Hematologic, 
Lymphoma - Non-Hodgkin's High Grade, 
Lymphoma - Non-Hodgkin's Intermediate Grade
Intent: Adjuvant, Curative
Funding:
New Drug Funding Program
    Rituximab (Biosimilar IV) and Rituximab SC - Retreatment - Aggressive Histology Lymphoma
New Drug Funding Program
    Rituximab (Biosimilar IV) and Rituximab SC - Retreatment - Aggressive Histology Lymphoma
Dec 2020
Drug
Other Name(s): Gleevec®
Dec 2024
Drug
Other Name(s): Zydelig™
Feb 2022
Drug
Other Name(s): Besponsa®
Jul 2023
Drug
Other Name(s): Camptosar®
Apr 2023
Drug
Other Name(s): Imbruvica®
Feb 2023
Drug
Other Name(s): Ifex® (multiple brands available)
Aug 2016
Drug
Other Name(s): Idamycin®
Oct 2023
Drug
Other Name(s): Yervoy®
Aug 2024
Drug
Other Name(s): Sarclisa®
Mar 2024
Drug
Other Name(s): Ninlaro™
Jun 2019

Pages